Improve Adherence1 with Home Kidney Testing
Close care gaps, improve outcomes, and reduce costs with Minuteful Kidney
Trusted by healthcare leaders
From 0% to 72% adherence2
8 in 10 Americans at risk for CKD don’t take their annual urine test. Reach the untested by enabling them to test themselves at their convenience.
Send a kit
ACR (albumin to creatinine ratio) test kit sent to eligible members
Member tests
Member takes the test at home using their smartphone
Review results
Results immediately available for the doctor to review and follow up
This new test has the potential to help millions of patients find out if they have CKD while there is still time to prevent progression to kidney failure.
Kerry Willis, PhD
Chief Scientific Officer, National Kidney Foundation
An official Healthy.io partner
33%
Adult Americans at risk of CKD
72%
Adherence rate reached using Minuteful Kidney
$120 billion
Medicare expenditure on CKD
Using Minuteful Kidney
The Minuteful Kidney test app and kit allow people to test themselves at home for signs of CKD and receive immediate clinical results. Using colorimetric analysis, computer vision, and AI we transform the smartphone camera into a clinical-grade medical device. The app walks the user through a simple test, making it as easy as snapping a photo
Validated outcomes for health plans3
Reduce the total cost of care by preventing progression of CKD, increase risk scoring, and improve quality metrics.
$708
3-year net gain per identified member
2yr
Positive return on investment
★★★★★
Additional gains from improved quality metrics
Smartphone-powered CKD early detection service
Scaling patient activation
We take care of the whole process. We ship and deliver kits to eligible members and ensure they take the test. Their doctors receive the results for follow-up.
Reducing health inequities
Engage previously untested members by giving them the freedom to test when it's most convenient for them, from the comfort of their home.
Intuitive testing
Our user-friendly app makes testing at home as easy as taking a photo. People of all ages can test in under 3 minutes, with a 98% user satisfaction rate.
Clinical results
Our AI and computer vision technology calibrates the dipstick scan and analyzes the results regardless of lighting conditions, setting, or device type, ensuring clinical-grade results.
Recommended Resources
Geisinger Health Rollout
How at-home screening improved adherence rates from 0% to 72% among previously untested, at-risk populations.
Read the clinical study
Tackling the $120BCKD Problem
More than 80 million Americans are at risk for CKD. New technologies and initiatives can help save lives and cut costs.
View the infographic
Changing Patient Behaviors
To improve outcomes, healthcare must find its way into patients' priorities and empower them to take control of their health.
Read the blog post
Make a difference for your at-risk members
Citations and Footnotes
- This device is currently limited to investigational use in the United States.
- Validated in a rollout with Geisinger Health, among consented untested population. BMC Nephrol 20, 132 (2019). https://doi.org/10.1186/s12882-019-1324-z
- Outcomes derived from a model performed by an external credentialed actuary. The model is based on actuarial evaluation of medical and pharmacy claims data representing 4.9 million members managed under Medicare Advantage and 12.7 million members managed under commercial plans. Net gain and ROI is calculated assuming proper management and treatment of the disease after diagnosis.